Search Results

Vitamins that are also Hormones Why That Changes How We Diagnose, Treat, and Think About It Below is a finished, physician-to-patient blog , aligned with your established template, tone, and educational depth. Vitamin D Is a Hormone — Not Just a Vitamin Most people think of vitamin D as a simple nutrient—something you take for bone health or to “boost immunity.” From a medical standpoint, that framing is incomplete and, at times, misleading. Vitamin D is not merely a vitamin. It functions as a steroid hormone , with widespread effects throughout the body. Understanding this distinction fundamentally changes how we evaluate deficiency, dosing, risk, and long-term health implications. Soy-Free Vitamin D3 in Olive Oil Why Vitamin D Breaks the Rules of Vitamins By definition, a vitamin is an essential nutrient that the body cannot manufacture in adequate amounts and must obtain from the diet. Vitamin D violates this definition in several important ways. The human body: Synthesizes vitamin D in the skin  in response to ultraviolet B (UVB) radiation Converts it through a two-step endocrine activation process Uses the active form to regulate gene expression These characteristics place vitamin D squarely in the category of hormones , not traditional vitamins. The Hormonal Activation Pathway Vitamin D undergoes a tightly regulated process similar to other steroid hormones: Skin:  UVB exposure converts 7-dehydrocholesterol into cholecalciferol (vitamin D₃) Liver:  Conversion to 25-hydroxyvitamin D [25(OH)D], the storage form measured in blood tests Kidney (and other tissues):  Conversion to 1,25-dihydroxyvitamin D (calcitriol), the active hormone Calcitriol binds to the vitamin D receptor (VDR) , a nuclear receptor found in over 30 different tissues , influencing the transcription of hundreds of genes. Vitamin D Receptors: Everywhere That Matters Differences between Vitamins and Minerals Vitamin D receptors are found far beyond bone and calcium pathways, including: Brain and central nervous system Immune cells (T cells, B cells, macrophages) Cardiovascular tissue Skeletal muscle Pancreatic beta cells Colon, breast, and prostate tissue This widespread receptor distribution explains why vitamin D status has been linked to outcomes far beyond osteoporosis. For Osteoporosis or Osteopenia, take Vitamin D3 with Vitamin K2 Clinical Roles of Vitamin D as a Hormone Bone and Mineral Metabolism Vitamin D regulates: Intestinal calcium and phosphorus absorption Bone remodeling Parathyroid hormone (PTH) suppression Deficiency leads not only to osteopenia and osteoporosis, but also increased fracture risk and impaired bone quality. Immune Modulation Vitamin D: Enhances innate immune defense Modulates inflammatory cytokine production Helps regulate autoimmune responses Low levels have been associated with increased susceptibility to respiratory infections and dysregulated immune activity. Muscle Function and Falls Adequate vitamin D levels support: Muscle strength Neuromuscular coordination Reduced fall risk in older adults Muscle weakness is often one of the earliest—and least recognized—signs of deficiency. Brain and Cognitive Health Vitamin D plays a role in: Neuroprotection Neurotransmitter regulation Reduction of neuroinflammation Emerging evidence links low vitamin D levels to cognitive decline and increased dementia risk, particularly in aging populations. Why Deficiency Is So Common Despite its importance, vitamin D deficiency is widespread—even in sunny climates. Contributing factors include: Limited sun exposure Sunscreen use and indoor lifestyles Aging skin (reduced synthesis) Obesity (vitamin D sequestration in fat tissue) Malabsorption syndromes Chronic kidney or liver disease Diet alone is rarely sufficient to maintain optimal levels. What Blood Levels Really Mean The standard test, 25-hydroxyvitamin D , reflects body stores—not active hormone levels. From a clinical perspective: Levels below 20 ng/mL indicate deficiency 20–30 ng/mL is often insufficient Many physicians aim for 30–50 ng/mL  to support broader physiologic functions Optimal targets may vary based on age, bone health, immune status, and comorbid disease. Why Dosing Requires Medical Judgment Because vitamin D is fat-soluble and hormonally active: Excessive dosing can lead to toxicity Calcium balance must be monitored Individual response varies widely Supplementation should be intentional, monitored, and personalized , not arbitrary. The Takeaway Calling vitamin D “just a vitamin” understates its importance and invites under-treatment. In reality, vitamin D functions as a master regulatory hormone  influencing bone, immune, muscle, and brain health. Recognizing this distinction allows patients and clinicians to move beyond casual supplementation toward evidence-based assessment, targeted dosing, and meaningful prevention . In upcoming posts, we’ll explore how vitamin D interacts with calcium, magnesium, hormones, and inflammation , and why balance—not megadosing—is the key to long-term health. References Holick MF.  Vitamin D deficiency. N Engl J Med.  2007;357(3):266–281. https://pubmed.ncbi.nlm.nih.gov/17634462/ DeLuca HF.  Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr.  2004;80(6 Suppl):1689S–1696S. https://pubmed.ncbi.nlm.nih.gov/15585789/ Christakos S, et al.  Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev.  2016;96(1):365–408. https://pubmed.ncbi.nlm.nih.gov/26681795/ Norman AW.  From vitamin D to hormone D: fundamentals of the vitamin D endocrine system. Am J Clin Nutr.  2008;88(2):491S–499S. https://pubmed.ncbi.nlm.nih.gov/18689389/ Bikle DD.  Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol.  2014;21(3):319–329. https://pubmed.ncbi.nlm.nih.gov/24529992/ Haussler MR, et al.  The nuclear vitamin D receptor: biological and molecular regulatory properties. J Bone Miner Res.  1998;13(3):325–349. https://pubmed.ncbi.nlm.nih.gov/9525333/ Bouillon R, et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev.  2008;29(6):726–776. https://pubmed.ncbi.nlm.nih.gov/18694980/ Prietl B, et al.  Vitamin D and immune function. Nutrients.  2013;5(7):2502–2521. https://pubmed.ncbi.nlm.nih.gov/23857223/ Aranow C.  Vitamin D and the immune system. J Investig Med.  2011;59(6):881–886. https://pubmed.ncbi.nlm.nih.gov/21527855/ Bischoff-Ferrari HA, et al.  Effect of vitamin D on falls: a meta-analysis. JAMA.  2004;291(16):1999–2006. https://pubmed.ncbi.nlm.nih.gov/15113819/ Wang Y, et al.  Vitamin D and risk of cardiovascular disease. Circulation.  2008;117(4):503–511. https://pubmed.ncbi.nlm.nih.gov/18180395/ Annweiler C, et al.  Vitamin D and cognition in older adults: updated systematic review. J Intern Med.  2013;273(6):509–522. https://pubmed.ncbi.nlm.nih.gov/23489360/ Eyles DW, et al.  Vitamin D and brain development. Neuroscience.  2013;118(3):641–653. https://pubmed.ncbi.nlm.nih.gov/12699736/ Pilz S, et al.  Vitamin D and mortality risk: a meta-analysis. Am J Clin Nutr.  2009;89(3):713–724. https://pubmed.ncbi.nlm.nih.gov/19116333/ Rosen CJ, et al.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev.  2012;33(3):456–492. https://pubmed.ncbi.nlm.nih.gov/22596255/ Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

St. John’s wort is often perceived as a gentle, plant-based option for mood support. Because it is sold over the counter and labeled as “natural,” many patients assume it is inherently safe. From a physician’s perspective, that assumption is not only incorrect—it can be dangerous . St. John’s wort is one of the most clinically significant drug-interacting supplements in widespread use today , capable of reducing the effectiveness of numerous prescription medications, sometimes with serious or life-threatening consequences.¹⁻³ St. John's Wort can cause drug interactions What Is St. John’s Wort? St. John’s wort ( Hypericum perforatum ) is an herbal preparation traditionally used for mild to moderate depression, anxiety, and mood symptoms. Its primary active constituents include hyperforin  and hypericin , compounds that exert effects on neurotransmitters such as serotonin, dopamine, and norepinephrine.¹,² While these properties explain its antidepressant effects, they also underpin its high risk for drug interactions . The Core Problem: Potent Enzyme Induction St. John’s wort is a strong inducer of hepatic and intestinal drug-metabolizing enzymes , particularly: Cytochrome P450 3A4 (CYP3A4) Cytochrome P450 2C9 and 2C19 P-glycoprotein (P-gp) transporters These systems are responsible for the metabolism and transport of a large proportion of commonly prescribed medications. When St. John’s wort induces these pathways, it accelerates drug clearance , often lowering blood levels below therapeutic thresholds.³⁻⁵ Importantly, this effect is not subtle—it can be profound. Tell your physician or Surgeon if you are taking this supplement. It can save your life. Medications Commonly Affected Antidepressants and Psychiatric Medications Combining St. John’s wort with SSRIs, SNRIs, tricyclic antidepressants, or other serotonergic agents increases the risk of serotonin syndrome , a potentially life-threatening condition characterized by agitation, hyperthermia, tremor, and autonomic instability.⁶⁻⁸ This interaction is especially concerning because patients often self-add St. John’s wort without informing their clinician . Oral Contraceptives St. John’s wort can significantly reduce estrogen and progestin levels, leading to contraceptive failure and unintended pregnancy .⁹⁻¹¹ Multiple case reports and pharmacokinetic studies have documented breakthrough bleeding and ovulation in women taking oral contraceptives alongside St. John’s wort.¹⁰,¹¹ Anticoagulants and Cardiovascular Drugs St. John’s wort reduces plasma concentrations of: Warfarin Direct oral anticoagulants Certain antiarrhythmics This interaction increases the risk of thromboembolic events , including stroke and pulmonary embolism.¹²,¹³ In patients with atrial fibrillation, prosthetic valves, or prior clotting events, this risk is particularly dangerous. Transplant and Immunosuppressive Medications Perhaps the most alarming interactions involve immunosuppressive agents , including cyclosporine and tacrolimus. St. John’s wort has been shown to precipitate acute transplant rejection  by lowering drug levels below therapeutic ranges.¹⁴,¹⁵ These interactions are well documented and widely cited in transplant medicine. Why These Interactions Are Often Missed Several factors contribute to under-recognition: Patients do not consider supplements to be “medications” Clinicians may not routinely ask about herbal products Effects may appear weeks after initiation Drug levels decline silently before clinical failure occurs This makes St. John’s wort uniquely hazardous—it often causes harm without immediate warning signs . “Natural” Does Not Mean Safe From a pharmacologic standpoint, St. John’s wort behaves more like a broad-spectrum enzyme-inducing drug  than a benign supplement. Its effects are: Dose dependent Sustained over time Clinically unpredictable between individuals Unlike prescription medications, there is no standardized dosing, formulation, or monitoring . Who Should Avoid St. John’s Wort Entirely? St. John’s wort should generally be avoided in patients who : Take prescription antidepressants Use hormonal contraception Take anticoagulants or cardiac medications Are transplant recipients Take seizure medications Are on complex or multiple drug regimens In these populations, the risks consistently outweigh any potential benefit.³⁻⁶,¹²⁻¹⁵ The Takeaway: St. John's Wort can be dangerous St. John’s wort is not a harmless herbal remedy. It is a potent modulator of drug metabolism  with the ability to reduce medication effectiveness, trigger dangerous interactions, and cause serious clinical harm. From a physician’s perspective, the most important message is this: Any supplement capable of altering liver enzymes must be treated like a prescription drug. Patients should never start St. John’s wort without discussing it with a qualified clinician—especially if they take prescription medications. Transparency, careful review, and medical oversight are essential to avoid preventable and potentially life-threatening outcomes. Taking Supplements Alongside Prescription Medications? Many “natural” products can interfere with critical drug therapies. At Stages of Life Medical Institute , we perform comprehensive medication and supplement reviews to identify hidden risks and prevent dangerous interactions. 👉 Schedule a medication and supplement safety review today. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. References: Barnes J, et al. St John’s wort (Hypericum perforatum): a review of its chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2001. https://pubmed.ncbi.nlm.nih.gov/11428685/ Linde K, et al. St John’s wort for depression—an overview and meta-analysis.  BMJ. 2008. https://pubmed.ncbi.nlm.nih.gov/18669545/ Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs.  Drugs. 2009. https://pubmed.ncbi.nlm.nih.gov/19453202/ Markowitz JS, et al. Effect of St John’s wort on cytochrome P450 enzymes.  Clin Pharmacol Ther. 2003. https://pubmed.ncbi.nlm.nih.gov/12576308/ Dresser GK, et al. Induction of P-glycoprotein by St John’s wort.  Clin Pharmacol Ther. 2003. https://pubmed.ncbi.nlm.nih.gov/12966369/ Mills E, et al. Herb–drug interactions: review.  Lancet. 2005. https://pubmed.ncbi.nlm.nih.gov/16023513/ Izzo AA. Herb–drug interactions with St John’s wort.  Drug Saf. 2004. https://pubmed.ncbi.nlm.nih.gov/15053437/ Boyer EW, Shannon M. The serotonin syndrome.  N Engl J Med. 2005. https://pubmed.ncbi.nlm.nih.gov/16079372/ Murphy PA, et al. St John’s wort and oral contraceptive failure.  Contraception. 2005. https://pubmed.ncbi.nlm.nih.gov/16022849/ Hall SD, et al. The interaction between St John’s wort and oral contraceptives.  Clin Pharmacol Ther. 2003. https://pubmed.ncbi.nlm.nih.gov/12891224/ Schwarz UI, et al. St John’s wort induces CYP3A4 and reduces contraceptive efficacy.  Clin Pharmacol Ther. 2003. https://pubmed.ncbi.nlm.nih.gov/12709724/ Jiang X, et al. Effect of St John’s wort on warfarin anticoagulation.  Br J Clin Pharmacol. 2004. https://pubmed.ncbi.nlm.nih.gov/15151530/ Piscitelli SC, et al. Induction of cytochrome P450 by St John’s wort.  Clin Infect Dis. 2000. https://pubmed.ncbi.nlm.nih.gov/10981743/ Ruschitzka F, et al. Acute heart transplant rejection due to St John’s wort.  Lancet. 2000. https://pubmed.ncbi.nlm.nih.gov/10920459/ Mai I, et al. Dangerous interaction between St John’s wort and cyclosporine.  Br J Clin Pharmacol. 2000. https://pubmed.ncbi.nlm.nih.gov/10930955/ Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

A Silent Driver of Atherosclerotic Cardiovascular Disease Introduction If you are truly interested in a healthy diet, if you are truly interested in learning the why and how of nutrition and nutritional medicine, this is article is an important investment of your valuable time. While it seems like a very dry, academic topic, it is likely to change your behavior in a meaningful and healthy way. Please share this one with your friends and family, it may change them, for the better, as well. Background Atherosclerotic cardiovascular disease (ASCVD) is often framed as a problem of cholesterol alone. While lipoproteins remain central, this view is incomplete. A growing body of evidence points to advanced glycation end products (AGEs)  as a powerful, under-recognized contributor to vascular aging, endothelial dysfunction, inflammation, and plaque instability. AGEs accumulate slowly and quietly over decades. By the time ASCVD becomes clinically evident, the biological damage has often been underway for years. Understanding AGEs changes how we think about cardiovascular risk, prevention, and longevity. What Are Advanced Glycation End Products? Advanced glycation end products causing cardiovascular disease, diabetes, kidney disease, neurodegeneration, and eye damage AGEs are harmful compounds formed when sugars react non-enzymatically with proteins, lipids, or nucleic acids, a process known as the Maillard reaction . This reaction accelerates under conditions common in modern life: Chronic hyperglycemia Insulin resistance and diabetes Oxidative stress High-temperature food preparation (grilling, frying, roasting) Once formed, AGEs are biologically persistent. They accumulate in long-lived tissues such as vascular collagen, myocardium, kidney, retina, and neural tissue¹². Endogenous vs Exogenous AGEs Endogenous AGEs Produced within the body as a consequence of: Elevated glucose exposure Mitochondrial oxidative stress Aging-related metabolic inefficiency Exogenous AGEs Absorbed directly from food, particularly: Charred meats Fried foods Baked and roasted products Ultra-processed foods Dietary AGEs significantly raise circulating AGE burden and inflammatory markers, independent of calories or macronutrient composition³⁴. How AGEs Promote ASCVD How Advanced Glycation End Products Form AGEs contribute to atherosclerosis through multiple converging mechanisms : 1. Endothelial Dysfunction AGEs cross-link collagen within the arterial wall, increasing stiffness and impairing nitric oxide signaling. The result is reduced vasodilation and increased shear stress⁵⁶. 2. Chronic Inflammation via RAGE AGE RAGE Pathway and Vascular Damage AGEs bind to the Receptor for Advanced Glycation End Products (RAGE) , activating NF-κB and sustaining low-grade vascular inflammation. This signaling loop perpetuates oxidative stress and cytokine production⁷⁸. 3. LDL Modification and Foam Cell Formation Glycated LDL is more readily oxidized and less efficiently cleared, promoting macrophage uptake and foam cell formation, a hallmark of early plaque development⁹. 4. Plaque Instability AGE accumulation weakens fibrous caps and promotes metalloproteinase activity, increasing the risk of plaque rupture and thrombosis¹⁰. AGEs, Diabetes, and “Residual Risk” Even in well-controlled diabetes, AGEs persist due to prior glycemic exposure, a phenomenon known as metabolic memory ¹¹. This explains why cardiovascular risk often remains elevated despite improved A1c levels. Importantly, AGE burden also rises in non-diabetic individuals  with insulin resistance, visceral adiposity, and sedentary lifestyles, making this a broader cardiometabolic issue¹². Clinical Markers and Assessment While AGEs are not yet part of routine cardiovascular screening, several surrogate indicators raise suspicion for elevated AGE burden: Elevated fasting insulin Increased HbA1c within “normal” range Oxidative stress markers Vascular stiffness (pulse wave velocity) Skin autofluorescence (research and select clinical settings)¹³ Reducing AGE Burden: Practical Strategies Nutrition Favor steaming, boiling, poaching over grilling or frying Emphasize whole, unprocessed foods Reduce refined carbohydrates and fructose exposure Glycemic Control Optimize insulin sensitivity Address post-prandial glucose excursions Antioxidant and Nutrient Support N-acetylcysteine (NAC) Alpha-lipoic acid Vitamin C and E Polyphenols (curcumin, resveratrol)¹⁴ Lifestyle Regular aerobic and resistance exercise Weight optimization Sleep and stress regulation What you can do, right now: Dietary Sources of Advanced Glycation End Products Control your sugar intake: Limit refined sugars, soft drinks, alcohol Modify cooking: Boil and steaming food is healthier than baking, frying and grilling (particularly over open flame) Eat whole (unprocessed) foods: A good start is the Mediterranean diet. These interventions reduce AGE formation, enhance clearance, and blunt RAGE-mediated inflammation¹⁵. Why This Matters Clinically AGEs provide a unifying mechanism  linking aging, diabetes, oxidative stress, and ASCVD. Addressing them shifts cardiovascular care from reaction to prevention and reframes risk assessment beyond cholesterol alone. For patients focused on longevity, vascular health, and cognitive preservation, AGE reduction represents a meaningful and actionable target. REFERENCES Brownlee M.  Biochemistry and molecular cell biology of diabetic complications. Nature . 2001;414(6865):813–820. https://pubmed.ncbi.nlm.nih.gov/11742414/ Singh R, et al.  Advanced glycation end-products: a review. Diabetologia . 2001;44(2):129–146. https://pubmed.ncbi.nlm.nih.gov/11270668/ Uribarri J, et al.  Dietary advanced glycation end products and their role in health and disease. Adv Nutr . 2015;6(4):461–473. https://pubmed.ncbi.nlm.nih.gov/26178075/ Vlassara H, et al.  Dietary glycotoxins. Proc Natl Acad Sci U S A . 2002;99(24):15596–15601. https://pubmed.ncbi.nlm.nih.gov/12429856/ Semba RD, et al.  Advanced glycation end products and arterial stiffness. J Gerontol A Biol Sci Med Sci . 2009;64A(7):742–748. https://pubmed.ncbi.nlm.nih.gov/19359445/ Goldin A, et al.  Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation . 2006;114(6):597–605. https://pubmed.ncbi.nlm.nih.gov/16894049/ Ramasamy R, et al.  Receptor for advanced glycation end products and inflammation. J Clin Invest . 2009;119(10):2523–2532. https://pubmed.ncbi.nlm.nih.gov/19729818/ Schmidt AM, et al.  RAGE signaling in vascular disease. Arterioscler Thromb Vasc Biol . 2010;30(8):1509–1517. https://pubmed.ncbi.nlm.nih.gov/20595672/ Bucala R, et al.  Modification of LDL by advanced glycation end products. Proc Natl Acad Sci U S A . 1994;91(20):9441–9445. https://pubmed.ncbi.nlm.nih.gov/7937785/ Basta G, et al.  Advanced glycation end products activate endothelial cells. Cardiovasc Res . 2004;63(2):267–275. https://pubmed.ncbi.nlm.nih.gov/15249186/ Ceriello A.  The concept of metabolic memory. Diabetes Care . 2009;32(Suppl 2):S245–S250. https://pubmed.ncbi.nlm.nih.gov/19875544/ Baynes JW.  Role of oxidative stress in development of complications in diabetes. Free Radic Biol Med . 2001;31(9):1157–1170. https://pubmed.ncbi.nlm.nih.gov/11677047/ Meerwaldt R, et al.  Skin autofluorescence as a measure of AGE accumulation. Diabetes Care . 2004;27(10):2246–2251. https://pubmed.ncbi.nlm.nih.gov/15451899/ Ziegler D, et al.  Alpha-lipoic acid in the treatment of diabetic neuropathy. Diabetes Care . 1999;22(8):1296–1301. https://pubmed.ncbi.nlm.nih.gov/10480775/ Uribarri J, et al.  Restriction of dietary advanced glycation end products improves insulin resistance. Diabetes Care . 2011;34(7):1610–1616. https://pubmed.ncbi.nlm.nih.gov/21617107/ The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

A Familiar but Important Pattern Seasonal Influenza Outbreaks are Predictable Each winter, influenza follows a somewhat predictable epidemiologic pattern. This season has been no exception. Influenza A  emerged early and aggressively, driving the initial surge in hospitalizations, urgent care visits, and missed work and school¹². More recently, Influenza B  has begun to circulate more widely, prolonging the overall flu season and catching many patients off guard³⁴. Understanding the differences between these two strains helps explain why flu symptoms may persist in the community even after the initial wave appears to subside. Influenza A: The Early and More Severe Wave Influenza A viruses are responsible for most seasonal epidemics and pandemics . They mutate rapidly and are often associated with more severe disease , particularly in older adults, young children, and those with chronic medical conditions⁵⁶. This season’s Influenza A outbreak was characterized by: High early transmission rates Increased emergency department utilization Significant systemic symptoms (high fever, myalgias, profound fatigue)¹⁷ Influenza A is also more likely to cause complications , including pneumonia, cardiac stress, and worsening of underlying pulmonary disease⁸⁹. Influenza B: The Later, Lingering Threat As Influenza A activity begins to decline, Influenza B often rises , particularly later in the flu season³¹⁰. While sometimes perceived as “milder,” Influenza B can still cause significant illness , especially in children, adolescents, and older adults¹¹¹². Notably: Influenza B circulates almost exclusively in humans It tends to spread later in the season It can prolong community-wide illness even when people believe “flu season is over”⁴¹³ Patients may assume they have a new respiratory virus or a “bad cold,” when in fact they are experiencing a second, distinct influenza infection . Why This Matters Clinically From a physician’s perspective, the sequential appearance of Influenza A followed by Influenza B explains why: Flu activity seems prolonged Patients may become ill twice in one season Ongoing vigilance remains necessary even late in winter¹⁴ Vaccination, early testing, and timely antiviral treatment remain essential tools, particularly for high-risk individuals¹⁵. Practical Takeaways for Patients Influenza A typically strikes earlier and harder Influenza B often extends the season Fever, body aches, cough, and fatigue should still prompt evaluation Antiviral treatment is most effective when started early Preventive measures remain important even late in the season Influenza is not a single event—it is a dynamic, evolving outbreak  that unfolds in phases. Summary This year’s influenza season has followed a classic but clinically important pattern: an early Influenza A surge followed by a later Influenza B wave . Recognizing this progression helps patients understand why flu activity persists and why ongoing awareness, testing, and prevention remain critical well beyond the initial outbreak. References Iuliano AD, et al. Estimates of global seasonal influenza-associated respiratory mortality. Lancet.  2018;391(10127):1285–1300. https://pubmed.ncbi.nlm.nih.gov/29248255/ Centers for Disease Control and Prevention. Disease burden of influenza. CDC.   https://pubmed.ncbi.nlm.nih.gov/30285306/ Caini S, et al. Characteristics of seasonal influenza B epidemics. PLoS One.  2015;10(3):e0120175. https://pubmed.ncbi.nlm.nih.gov/25760637/ Paul Glezen W, et al. Influenza B virus circulation patterns. J Infect Dis.  2013;208(2):271–279. https://pubmed.ncbi.nlm.nih.gov/23570866/ Taubenberger JK, Morens DM. Influenza viruses: pathogenesis and host response. Annu Rev Pathol.  2008;3:499–522. https://pubmed.ncbi.nlm.nih.gov/18233933/ Webster RG, et al. Evolution and ecology of influenza A viruses. Microbiol Rev.  1992;56(1):152–179. https://pubmed.ncbi.nlm.nih.gov/1579108/ Monto AS, et al. Medical practice burden of influenza. Clin Infect Dis.  2004;38(4):483–491. https://pubmed.ncbi.nlm.nih.gov/14765342/ Madjid M, et al. Influenza and cardiovascular disease. J Am Coll Cardiol.  2004;44(5):1178–1182. https://pubmed.ncbi.nlm.nih.gov/15337215/ Jain S, et al. Hospitalized patients with 2009 H1N1 influenza. N Engl J Med.  2009;361(20):1935–1944. https://pubmed.ncbi.nlm.nih.gov/19815859/ Heikkinen T, et al. Influenza B in children. Pediatr Infect Dis J.  2004;23(7):674–679. https://pubmed.ncbi.nlm.nih.gov/15247640/ Tran D, et al. Hospitalization burden of influenza B. Clin Infect Dis.  2016;63(12):1525–1532. https://pubmed.ncbi.nlm.nih.gov/27578820/ Chiu SS, et al. Influenza B severity in children. Clin Infect Dis.  2002;35(6):669–679. https://pubmed.ncbi.nlm.nih.gov/12203164/ Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother.  2012;8(1):81–88. https://pubmed.ncbi.nlm.nih.gov/22252006/ Uyeki TM, et al. Clinical practice guidelines for influenza. Clin Infect Dis.  2019;68(6):e1–e47. https://pubmed.ncbi.nlm.nih.gov/30834477/ Jefferson T, et al. Neuraminidase inhibitors for influenza. Cochrane Database Syst Rev.  2014;4:CD008965. https://pubmed.ncbi.nlm.nih.gov/24718923/ Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

A physician’s guide for patients—clear, evidence-based, and practical. Most people take vitamins, yet surprisingly few understand what a vitamin actually is. The term is often used loosely to describe anything sold in a supplement aisle, but in medicine and biology, vitamins have a precise definition . Understanding that definition—and where important exceptions exist—helps patients make better decisions about nutrition, supplementation, and long-term health. A clear definition A vitamin  is an organic compound  required in small amounts  for normal metabolism, cellular function, growth, and repair— and one that the human body cannot synthesize in adequate quantities on its own . This definition matters. If the body can make enough of a substance, it is not  a vitamin. If the substance is inorganic (such as calcium or iron), it is a mineral , not a vitamin . Vitamins occupy a narrow but essential biological category. The two major vitamin families Vitamins are traditionally classified by how they are absorbed, transported, and stored. Fat-soluble vitamins Fat-soluble vitamins dissolve in dietary fat, are absorbed through the intestinal lymphatic system, and can be stored in body tissues , particularly the liver and adipose tissue. They include: Vitamin A Vitamin D Vitamin E Vitamin K Because they are stored, deficiencies usually develop slowly—but excessive intake can accumulate and cause toxicity . An important exception: vitamin D Although vitamin D is traditionally grouped with fat-soluble vitamins, it functions biologically as a hormone, not a true vitamin . Unlike other vitamins, vitamin D can be synthesized by the human body  when ultraviolet B (UVB) sunlight interacts with cholesterol in the skin. It is then activated in the liver and kidneys to form calcitriol , a steroid (secosteroid) hormone that binds to nuclear receptors and directly regulates gene expression . Vitamin D receptors are found throughout the body, including bone, muscle, immune cells, the cardiovascular system, and the brain. This explains why vitamin D affects bone health, immune regulation, inflammation, insulin sensitivity, neuromuscular function, and more. It remains labeled a “vitamin” largely for historical reasons, because deficiency was first recognized through dietary disease (rickets). Clinically, it is more accurate to think of vitamin D as a hormone with vitamin-like deficiency states , which is why blood testing and individualized dosing are often appropriate. Water-soluble vitamins Water-soluble vitamins dissolve in water, circulate freely in the bloodstream, and excess amounts are usually excreted in urine. They include: Vitamin C B-complex vitamins (B1, B2, B3, B5, B6, B7, B9, B12) Because they are not extensively stored, deficiencies can develop more quickly, particularly with poor intake, malabsorption, medication effects, or increased metabolic demand. Vitamins vs hormones: a simple comparison Many patients are surprised to learn that vitamin D behaves more like a hormone than a vitamin. The distinction is helpful. In simple terms: Vitamins  must come primarily from the diet and act mainly as enzyme cofactors. Hormones  are produced in the body, circulate as signaling molecules, and regulate gene expression and organ function. Vitamin D sits at the intersection of these categories. What vitamins actually do Vitamins do not  provide energy or calories. Instead, they enable the chemical reactions that allow cells to function. They commonly act as: Enzyme cofactors Regulators of cellular metabolism Antioxidants Facilitators of neurotransmitter and hormone synthesis Without adequate vitamin availability, metabolic pathways slow or malfunction—even when calories are plentiful. Why deficiencies still occur Vitamin deficiency is not confined to poverty or famine. Subclinical deficiency is common, especially in older adults. Common contributors include: Highly processed diets Reduced appetite or restrictive eating Gastrointestinal disorders or surgery Certain medications (e.g., metformin, proton-pump inhibitors) Reduced sun exposure Increased needs with aging, illness, or stress Symptoms are often subtle at first—fatigue, neuropathy, cognitive slowing, immune vulnerability, or bone loss. Food first—usually Whole foods remain the preferred source of vitamins because they provide supportive nutrients that enhance absorption and utilization. Examples include: Leafy greens → folate, vitamin K Fatty fish → vitamin D, vitamin A Citrus and vegetables → vitamin C Eggs and meats → B12, biotin However, food alone does not always meet needs. Great value in GMP quality Vitamins & Minerals for less than $26 per month When supplementation is appropriate Supplementation is often reasonable when: A deficiency is documented Absorption is impaired Dietary intake is consistently inadequate Requirements increase with age or illness Evidence supports benefit in deficient individuals The goal is targeted supplementation , not indiscriminate use. More is not better Excess intake—particularly of fat-soluble vitamins—can cause harm. The objective is physiologic adequacy , not maximal dosing. Bottom line A vitamin is not a marketing term or wellness trend. It is a biologically essential compound required for normal human physiology. Vitamin D stands apart as a hormone that behaves like a vitamin only in deficiency. Understanding these distinctions empowers patients to approach nutrition and supplementation with clarity, realism, and safety—ideally guided by medical evidence and individualized care. References Combs GF. The Vitamins: Fundamental Aspects in Nutrition and Health.  Elsevier; 2012. Ames BN. Low micronutrient intake may accelerate aging. Proc Natl Acad Sci USA.  2006;103(47):17589-17594. https://pubmed.ncbi.nlm.nih.gov/17101960/ Holick MF. Vitamin D deficiency. N Engl J Med.  2007;357:266-281. https://pubmed.ncbi.nlm.nih.gov/17634462/ Christakos S, et al. Vitamin D metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev.  2016;96(1):365-408. https://pubmed.ncbi.nlm.nih.gov/26681795/ O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients.  2010;2(3):299-316. https://pubmed.ncbi.nlm.nih.gov/22254022/ Troesch B, et al. Increased micronutrient needs with aging. Clin Interv Aging.  2012;7:231-245. https://pubmed.ncbi.nlm.nih.gov/22888231/ NIH Office of Dietary Supplements. Vitamins and Minerals Fact Sheets. https://pubmed.ncbi.nlm.nih.gov/ Schleicher RL, et al. Trends in vitamin status in the U.S. population. Am J Clin Nutr.  2016;103(1):274-284. https://pubmed.ncbi.nlm.nih.gov/26702154/ EFSA Panel. Tolerable upper intake levels for vitamins. EFSA J.  2018. https://pubmed.ncbi.nlm.nih.gov/ Institute of Medicine. Dietary Reference Intakes for Vitamins.  National Academies Press; 2011. Subscribe to our Blog   Sponsored by Stages of Life Vitamins 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Migraine vs. Sinus Headache Why the Difference Matters—and How to Tell Them Apart Migraines and sinus headaches can strike anytime, anywhere—and both can be painful enough to derail your day. Because their symptoms often overlap, many people assume they’re having a “sinus headache” when the true cause is migraine. Understanding the difference matters. The correct diagnosis leads to the correct treatment—and faster, more reliable relief. What Is a Migraine? A migraine  is a neurological disorder, not a sinus problem. It is characterized by moderate to severe head pain that is often throbbing or pulsating and commonly affects one side of the head. Migraine attacks are frequently accompanied by additional symptoms that reflect involvement of the nervous system. Common Migraine Features Throbbing or pulsing head pain (often one-sided) Nausea and/or vomiting Sensitivity to light (photophobia) Sensitivity to sound (phonophobia) Worsening pain with routine physical activity Visual or sensory aura  in some individuals Importantly, nasal symptoms can also occur during migraine , including: Runny or stuffy nose Watery eyes Facial pressure These nasal features are a major reason migraines are mistaken for sinus headaches. Why “Sinus Migraine” Is a Common Mislabel Both migraines and sinus conditions can cause: Facial pain or pressure Nasal congestion or drainage Watery eyes Because migraine can activate autonomic nerves that affect the nose and eyes, it may feel  like a sinus problem—especially during allergy season or after a cold. In fact, studies consistently show that up to 90% of self-diagnosed sinus headaches are actually migraines . Who Is at Risk for Migraine? Migraines can affect anyone, but certain factors increase risk: Women are affected about three times more often than men Family history of migraine Hormonal fluctuations Co-existing conditions such as anxiety, depression, or sleep disorders What Is a True Sinus Headache? A sinus headache  occurs when the lining of the sinus cavities becomes inflamed—a condition known as sinusitis . The pain results from pressure and inflammation within the sinuses, not from neurological activation. True sinus headaches are far less common than people think. Typical Features of Sinusitis-Related Headache Pressure or fullness in the cheeks, forehead, or between the eyes Thick nasal discharge (often yellow or green) Nasal congestion and postnasal drip Tooth pain or jaw discomfort Reduced sense of smell Fever (in some cases) Pain that worsens when bending forward Key Differences: Migraine vs. Sinus Headache Pain Quality and Location Migraine:  Pulsing or throbbing pain, often unilateral, worsened by activity Sinus headache:  Deep, pressure-like pain over the sinuses with localized tenderness Associated Symptoms Migraine:  Nausea, light and sound sensitivity, possible aura; nasal symptoms may occur Sinus headache:  Thick nasal discharge, congestion, postnasal drip, fever, reduced smell Duration Migraine:  Typically lasts 4–72 hours  per attack Sinusitis-related headache:  Persists 7–10 days or longer , tracking the course of infection or inflammation Why Misdiagnosis Is So Common Migraines frequently cause nasal congestion and watery eyes, mimicking sinus disease. When this happens during allergy season or following a cold, the assumption of sinusitis is easy—but often incorrect. Decongestants may offer little or no relief in migraine, which is another important diagnostic clue. How an Accurate Diagnosis Is Made Clinical Evaluation Matters Most A careful medical history and focused exam are usually sufficient to distinguish migraine from sinus headache. Important clues include: Presence of nausea or light/sound sensitivity Triggers such as stress, sleep disruption, or skipped meals Family history of migraine Response (or lack of response) to sinus medications Role of Imaging Sinus imaging (CT or endoscopy):  Reserved for chronic, recurrent, or complicated sinus disease Brain imaging:  Not routinely needed for stable, typical migraine Treatment Options Migraine Treatment Acute (Abortive) Therapy NSAIDs or acetaminophen at symptom onset Triptans Newer agents such as gepants (CGRP receptor antagonists)  and ditans , which offer alternatives for patients who cannot tolerate or should avoid older therapies Preventive Therapy CGRP monoclonal antibodies Beta-blockers Topiramate Certain antidepressants OnabotulinumtoxinA (Botox) for chronic migraine Lifestyle Foundations Regular sleep and meals Adequate hydration Stress management Trigger identification and avoidance Sinus Headache (Sinusitis) Treatment Symptom Relief Saline nasal irrigation Intranasal corticosteroid sprays Humidification Short-term use of topical decongestants (no more than 3–5 days) Antibiotics Not routinely needed Considered only when criteria for bacterial sinusitis are met Chronic or Recurrent Cases Evaluation for allergies or structural issues ENT referral when appropriate Surgery is rarely required When to Seek Specialty Care Consider further evaluation if: “Sinus headaches” are accompanied by nausea or light/sound sensitivity Headaches last 4–72 hours and recur despite sinus treatments Facial pain and congestion persist beyond 10–14 days or keep returning Urgent care is needed  for red flags such as: Sudden, severe “worst headache of life” New neurological symptoms High fever, stiff neck, or vision changes Bottom Line Most headaches labeled as “sinus” are actually migraines. Recognizing the difference can prevent years of ineffective treatment and open the door to therapies that truly work. A thoughtful medical evaluation—not guesswork—is the key to lasting relief. References American Migraine Foundation – Migraine vs. Sinus Headache:  overview of symptoms and frequent misdiagnosis of migraine as sinus headache. Migraine vs. Sinus Headache (AMF)   American Migraine Foundation Saberi A, et al. Association between allergic rhinitis and migraine  — links allergic symptoms with migraine and facial pain overlap. Association between allergic rhinitis and migraine (PMC)   PMC Al-Hashel JY, et al. Migraine misdiagnosis as sinusitis  — high rate of migraine misdiagnosis and diagnostic delay. Migraine misdiagnosis as sinusitis (PMC)   PMC Al Kadri L, et al. Assessing the relationship between migraine and sino  — summarizes that up to 90% of suspected sinus headaches meet migraine criteria. Migraine vs Sino Headache Prevalence (PMC)   PMC Straburzyński M, et al. Etiology of ‘Sinus Headache’  — review showing that many “sinus headaches” are actually migraine. Etiology of Sinus Headache Review (PMC)   PMC Cady RK, et al. Sinus headache or migraine?  — clinical and pathophysiologic relationships between sinus symptoms and migraine. Sinus headache vs Migraine (PubMed)   PubMed WebMD – Migraine vs. Sinus Headache:  reputable clinical guide on overlapping symptoms and diagnostic considerations. WebMD: Migraine vs. Sinus Headache   WebMD Mayo Clinic Health System – Your sinus headache may not be what you think:  explains sinus headache vs migraine misinterpretation and high misdiagnosis rates. Mayo Clinic: Sinus vs Migraine   Mayo Clinic Health System American Family Physician – Migraine Headache Often Labeled as Sinus Headache  — notes frequent misattribution of headache type. Migraine Labeled as Sinus Headache (AAFP)   AAFP Schreiber CP, et al. Prevalence of migraine among patients with self-described sinus headaches  — demonstrates that ~88% of “sinus” headache cases meet migraine criteria. JAMA Internal Medicine: Migraine Prevalence Study   JAMA Network Yuan H, et al. Debunking myths in headache diagnosis  — describes observational evidence that most self-described sinus headache cases satisfy migraine criteria. Debunking Headache Misdiagnosis (BMJ)   rapm.bmj.com MigraineCanada.org – Deciphering Sinus Headaches:  summary of research showing majority of sinus-type headaches are actually migraine. MigraineCanada: Sinus Headaches vs Migraine   Migraine Canada Mayo Clinic Proceedings – Sinus Headache: A Neurology/Otolaryngology/Allergy Perspective  — evidence supporting misattribution of sinus symptoms to migraine. Sinus Headache Clinical Review (Mayo Clin Proc)   Mayo Clinic Proceedings Harvard Health Publishing – Sinus headache or migraine?  — practical discussion of misdiagnosis in clinical practice. Harvard Health: Sinus vs Migraine   Harvard Health ENT Allergy PDF – Why your sinus headache is almost definitely a migraine  — reporting high misdiagnosis rates from migraine studies presented at headache society meetings. Sinus Headache vs Migraine Study (ENTAD)   ENT & Alle Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

What Is a Mineral? A physician’s guide for patients—clear, evidence-based, and practical. This article is part of an ongoing physician-written educational series exploring vitamins, minerals, and supplements across the lifespan. If you are new to the series, you may wish to begin with “What Is a Vitamin?” , which establishes the foundational concepts used throughout. Minerals are discussed far less often than vitamins, yet they are just as essential to human health. They build our bones, regulate heartbeat and nerve signaling, control fluid balance, and enable hundreds of enzymatic reactions. Despite this, minerals are frequently misunderstood or casually grouped with “supplements,” even though they have a precise medical definition and well-described deficiency states. This article explains what a mineral is , how minerals differ from vitamins and hormones, why deficiencies still occur in modern societies, and when supplementation is appropriate. A clear definition A mineral  is an inorganic element  required in specific amounts  for normal structure, metabolism, and physiologic regulation— and one that the human body cannot synthesize . Several features distinguish minerals from other nutrients: They are elements , not organic molecules They originate from the earth (soil and water) and enter the food chain through plants and animals They cannot be created by human cells They retain their elemental identity throughout digestion and metabolism If a substance is organic, it is not a mineral. If it can be synthesized by the body, it is not essential. Minerals occupy a foundational role in human biology. Major minerals vs trace minerals Minerals are classified by the quantities required by the body. Major (macrominerals) These are needed in relatively larger amounts (hundreds of milligrams to grams per day): Calcium Magnesium Sodium Potassium Chloride Phosphorus They are central to bone structure, muscle contraction, nerve conduction, acid–base balance, and fluid regulation. Trace minerals These are required in much smaller amounts (milligrams or micrograms per day), yet they are no less important: Iron Zinc Copper Selenium Iodine Manganese Chromium Molybdenum Strontium Trace minerals most often act as enzyme cofactors , enabling biochemical reactions that would otherwise fail. What minerals actually do: Minerals do not provide calories or energy. Instead, they allow the body’s systems to function correctly. Broadly, minerals are involved in: Structural integrity  (calcium and phosphorus in bone and teeth) Electrical signaling  (sodium, potassium, calcium in nerves and muscle) Enzyme activation  (magnesium, zinc, copper) Hormone synthesis  (iodine in thyroid hormone) Oxygen transport  (iron in hemoglobin) Antioxidant defense  (selenium in glutathione peroxidase) Without adequate mineral availability, physiologic processes slow, misfire, or fail—even when vitamin intake is excellent. How minerals differ from vitamins and hormones Minerals are often discussed alongside vitamins, but they are fundamentally different in structure and function. In simple terms: Minerals  are inorganic elements that provide structure and enable biochemical reactions Vitamins  are organic compounds that facilitate metabolic processes Hormones  are signaling molecules produced by the body that regulate gene expression and organ function Minerals do not regulate genes directly, but they are indispensable to the enzymes, tissues, and signaling systems that allow vitamins and hormones to do their work. Why mineral deficiencies still occur Mineral deficiency is not limited to famine or extreme malnutrition. In modern societies, subclinical mineral insufficiency is common , particularly with aging. Common contributors include: Highly processed diets with low mineral density Reduced intake of whole foods and vegetables Gastrointestinal disorders or prior GI surgery Chronic kidney or endocrine disease Certain medications (diuretics, proton-pump inhibitors) Excessive sweating or endurance exercise Reduced stomach acid impairing absorption Symptoms often develop gradually: muscle cramps, fatigue, palpitations, brittle nails, hair changes, impaired immunity, or cognitive changes. Food remains the preferred source Whole foods remain the most reliable way to obtain minerals in physiologic ratios. Examples include: Leafy greens → magnesium, calcium Nuts and seeds → magnesium, zinc Seafood → iodine, selenium Meats → iron, zinc Legumes → potassium, magnesium Food sources provide minerals alongside proteins, fats, and organic acids that enhance absorption and reduce imbalance. Best Value in Chelated Minerals for $27 per month. GMP Quality When supplementation makes sense Mineral supplementation is appropriate when: A deficiency is documented Dietary intake is inadequate Absorption is impaired Losses are increased (sweating, diarrhea, kidney disease) Requirements increase with age or illness Unlike many vitamins, minerals compete with one another for absorption . Excess intake of one mineral (for example, zinc) can impair absorption of another (such as copper). This is why indiscriminate supplementation can create unintended imbalances. More is not better Minerals have relatively narrow therapeutic windows. Excess intake can cause harm: Too much calcium may increase kidney stone risk Excess iron can damage the liver and heart High sodium intake raises blood pressure Excess potassium can cause dangerous cardiac arrhythmias The goal is adequacy and balance , not maximal intake. What’s next in this series In upcoming articles, we’ll explore what supplements really are , how the body absorbs nutrients, why deficiencies are often missed, and how to build a rational, individualized supplement strategy. Bottom line A mineral is an essential inorganic element without which human physiology cannot function. Minerals build structure, enable nerve and muscle activity, support enzyme systems, and allow vitamins and hormones to do their work. Understanding what minerals are—and how they differ from vitamins and hormones—helps patients make informed decisions about diet, supplementation, and long-term health. When guided by evidence and individualized assessment, minerals support vitality. When misused, they can create imbalance. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride.  National Academies Press; 2011. Nielsen FH. Micronutrients in parenteral nutrition. Gastroenterology.  2009;137(5 Suppl):S55–S60. https://pubmed.ncbi.nlm.nih.gov/19874949/ Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients.  2015;7(9):8199–8226. https://pubmed.ncbi.nlm.nih.gov/26404370/ Zimmermann MB. Iodine deficiency. Endocr Rev.  2009;30(4):376–408. https://pubmed.ncbi.nlm.nih.gov/19515928/ Beard JL. Iron biology in immune and neuronal function. J Nutr.  2001;131(2S-2):568S–579S. https://pubmed.ncbi.nlm.nih.gov/11160590/ Prasad AS. Zinc in human health. Mol Med.  2008;14(5-6):353–357. https://pubmed.ncbi.nlm.nih.gov/18385818/ Volpe SL. Magnesium and the athlete. Curr Sports Med Rep.  2015;14(4):279–283. https://pubmed.ncbi.nlm.nih.gov/26166091/ Rayman MP. Selenium and human health. Lancet.  2012;379(9822):1256–1268. https://pubmed.ncbi.nlm.nih.gov/22381456/ Heaney RP. Calcium and bone health. J Am Coll Nutr.  2000;19(2 Suppl):83S–99S. https://pubmed.ncbi.nlm.nih.gov/10759135/ NIH Office of Dietary Supplements. Minerals Fact Sheets. https://pubmed.ncbi.nlm.nih.gov/What is a mineral? A physician explains essential minerals, deficiency, supplementation, and how minerals differ from vitamins and hormones. Subscribe to our Blog   www.stagesoflifevitamins.com 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Be Prepared. Test Early. Treat Promptly. We are seeing a clear seasonal uptick in influenza , particularly Influenza A, with Influenza B beginning to follow—an expected epidemiologic pattern as respiratory virus season accelerates¹⁷. At the same time, COVID-19 continues to circulate , often presenting with symptoms indistinguishable from influenza in the early phase²⁸. Clinically, this overlap increases the risk of delayed testing and missed treatment windows , particularly for influenza where antiviral therapy is time-sensitive¹². This is not a message of alarm—it is a message of preparation. Two Viruses. Similar Symptoms. Different Treatments. Early Influenza Symptoms and When to Test Influenza and COVID-19 frequently present with overlapping symptoms, especially in the first 24–72 hours³¹¹: Fever or chills Headache and body aches Fatigue Sore throat Cough or chest tightness Because treatment strategies differ , identifying the causative virus matters—particularly during the first 48 hours of illness , when antiviral therapy for influenza is most effective¹²⁶. At-Home Testing: Essential This Season Home testing for COVID Influenza A and Influenza B Every household should keep combined at-home influenza and COVID-19 rapid tests  available before  symptoms begin⁸¹³. My advice is to get several boxes, as you will likely be testing yourself more than once. Testing should occur immediately at symptom onset , not after several days of illness: Positive for influenza  → antiviral therapy may be indicated¹² Positive for COVID-19  → supportive care and risk-based treatment decisions Negative but symptomatic  → repeat testing in 24 hours if symptoms persist⁸ Early testing is the gateway to effective treatment and complication reduction¹⁴. Influenza Vaccination: Still Worth Discussing Influenza vaccination remains a reasonable preventive strategy, particularly for adults over 50 and those with chronic medical conditions¹⁵. As with COVID vaccination, immunity is not absolute  and does not reliably prevent infection. Its primary benefit is reduction in disease severity, hospitalization, and complications , not sterilizing immunity¹⁵. Where Exposure Risk Is Highest Transmission risk increases substantially in enclosed, high-density environments⁷¹¹: Airports and airplanes Crowded indoor venues Schools and households with children Social gatherings during peak season There is no practical way to eliminate exposure—only to manage risk intelligently . What Actually Helps Prevent Infection Hand Hygiene Frequent handwashing remains one of the most effective defenses against both influenza and COVID-19 , reducing contact transmission from contaminated surfaces⁷. Masks Masks are situational and a matter of personal choice. Their greatest benefit may be behavioral reinforcement  in high-risk environments rather than absolute protection. Eating Out Prefer hot foods and hot beverages Avoid shared utensils or drinking vessels Use caution with cold or uncooked foods What to Have on Hand — Before  You Get Sick Early treatment gives the best result. Having these products on hand is like having a fire extinguisher handy, in case of fire. Over-the-Counter Support N-Acetylcysteine (NAC)  — 500 mg, four times daily Guaifenesin  — 400 mg, four times daily Licorice Root Extract  — one capsule twice daily Lactoferrin-containing colostrum  — two capsules, four times daily These agents support mucus clearance, oxidative balance, and immune modulation, and appear most effective when initiated early in viral illness ⁹¹⁰. Influenza-Specific Prescription Therapy: Tamiflu (Oseltamivir) Tamiflu for Influenza When Tamiflu Works Best Oseltamivir demonstrates its greatest clinical benefit when started within 48 hours of symptom onset ¹²⁶. After this window, benefit diminishes but may still be considered in higher-risk patients⁴. Standard Adult Dosing 75 mg by mouth, twice daily for 5 days ¹² Who Benefits Most Adults over 50 Patients with chronic cardiopulmonary, metabolic, or immune conditions Individuals with significant fever, myalgias, or rapid clinical decline⁴⁹ Tamiflu does not cure influenza, but it can shorten illness duration, reduce symptom severity, and lower complication risk  when used appropriately¹⁴. COVID-19 Treatment Considerations COVID-19 management remains individualized. Many patients require only supportive care, while higher-risk individuals may benefit from additional therapy²⁸. Vaccination status does not eliminate infection risk, and severity—not mere positivity—defines clinical concern ². Final Takeaway This is influenza season , and COVID-19 remains present . Test early Treat promptly Prepare in advance Avoid delay and denial Prepared patients consistently fare better than reactive ones. References Uyeki TM, et al. Clinical Practice Guidelines for the Diagnosis and Treatment of Influenza.   Clin Infect Dis.  2019;68(6):e1–e47. doi:10.1093/cid/ciy866 Centers for Disease Control and Prevention. Influenza Antiviral Medications: Summary for Clinicians.  Updated 2024. Treanor JJ. Influenza Viruses, Including Avian Influenza and Swine Influenza.   N Engl J Med.  2005;353:1574–1585. doi:10.1056/NEJMra052639 Muthuri SG, et al. Effectiveness of Neuraminidase Inhibitors in Reducing Mortality in Influenza.   Lancet Respir Med.  2014;2(5):395–404. doi:10.1016/S2213-2600(14)70041-4 Jefferson T, et al. Neuraminidase Inhibitors for Preventing and Treating Influenza.   Cochrane Database Syst Rev.  2014;4:CD008965. Hayden FG, et al. Use of the Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza.   JAMA.  1999;282(13):1240–1246. doi:10.1001/jama.282.13.1240 World Health Organization. Influenza (Seasonal): Fact Sheet.  Updated 2024. Centers for Disease Control and Prevention. Overview of Testing for SARS-CoV-2 and Influenza Viruses.  Updated 2024. Butler CC, et al. Effect of Antiviral Treatment on Influenza Symptoms and Complications.   BMJ.  2020;368:l6985. Fiore AE, et al. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza.   MMWR Recomm Rep.  2011;60(RR-1):1–24. Taubenberger JK, Morens DM. The Pathology of Influenza Virus Infections.   Annu Rev Pathol.  2008;3:499–522. Uyeki TM. Influenza.   Ann Intern Med.  2017;167(5):ITC33–ITC48. Peeling RW, et al. Diagnostics for COVID-19: Rapid Tests and Their Role.   Lancet Infect Dis.  2022;22(5):e1–e12. Brendish NJ, et al. Impact of Point-of-Care Testing for Respiratory Viruses.   Lancet Respir Med.  2017;5(5):401–411. Nichol KL, et al. Influenza Vaccination and Reduction in Hospitalization and Death.   N Engl J Med.  2003;348:1322–1332. This article is for educational purposes only and is not intended as a substitute for individualized medical advice, diagnosis, or treatment. Medication decisions should be made in consultation with a licensed healthcare professional, based on individual medical history and risk factors. Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

THC Cannabinol Introduction: Why Sleep Architecture Matters Sleep is not a single, uniform state. It is a highly organized biological process composed of repeating cycles of non-rapid eye movement (NREM)  sleep and rapid eye movement (REM)  sleep. These stages serve distinct and essential functions—ranging from physical restoration to memory consolidation and emotional regulation. In clinical practice, many patients report that tetrahydrocannabinol (THC) —the primary psychoactive compound in cannabis—“helps them sleep.” While THC may shorten sleep onset, a growing body of evidence demonstrates that it alters sleep architecture , particularly by suppressing REM sleep , fragmenting normal cycles, and impairing long-term sleep quality¹–³. Understanding this distinction— sleep quantity versus sleep quality —is critical for patients using THC regularly, whether recreationally or medicinally. A Brief Review of Normal Sleep Architecture Normal Sleep Architecture A typical adult night of sleep consists of 4–6 cycles , each lasting approximately 90–110 minutes⁴. NREM Stage N1:  Light transitional sleep NREM Stage N2:  Stable sleep; memory integration begins NREM Stage N3 (Slow-Wave Sleep):  Deep, restorative sleep REM Sleep:  Dreaming, emotional processing, procedural memory consolidation REM sleep becomes progressively longer toward morning and plays a disproportionate role in learning, mood regulation, and cognitive resilience⁵,⁶ . Disruption of this architecture—especially REM suppression—has measurable neurocognitive and emotional consequences. THC Disrupts Normal and Healthy Sleep Architecture The Endocannabinoid System and Sleep Regulation The endocannabinoid system (ECS)  is deeply involved in sleep-wake regulation. CB1 receptors are densely expressed in brain regions governing circadian rhythm, arousal, and memory—including the hypothalamus, hippocampus, and brainstem⁷ . THC acts as a partial agonist at CB1 receptors , producing dose-dependent effects on sleep: Acute sedation Reduced sleep latency Altered neurotransmitter release (acetylcholine, serotonin, norepinephrine) However, these same mechanisms interfere with REM generation , particularly through cholinergic suppression in the pontine tegmentum⁸. THC and REM Sleep Suppression Acute Effects Short-term THC exposure consistently demonstrates: Reduced REM duration Delayed REM onset Decreased REM density (eye movements per minute) ¹,² Polysomnographic studies confirm that while total sleep time may increase slightly, REM sleep is disproportionately reduced⁹. Chronic Use With repeated exposure, the effects become more pronounced: Persistent REM suppression Blunted REM rebound Increased sleep fragmentation Reduced slow-wave sleep in some individuals¹⁰,¹¹ Clinically, patients may describe this as “sleeping through the night” while simultaneously reporting non-restorative sleep , vivid dreams only after stopping THC, or worsening anxiety and memory over time. REM Rebound and Cannabis Withdrawal When THC is discontinued—particularly after chronic use—the brain attempts to compensate through REM rebound : Markedly increased REM duration Intensely vivid or disturbing dreams Nightmares Frequent awakenings¹² These symptoms often peak within 3–7 days of cessation  and may persist for several weeks, contributing to relapse in habitual users. From a sleep-medicine perspective, REM rebound is strong evidence that REM suppression was present and physiologically significant. Cognitive, Emotional, and Metabolic Consequences REM sleep is not optional. Chronic REM disruption has been associated with: Impaired emotional regulation and increased anxiety⁶ Reduced memory consolidation and learning efficiency⁵ Increased pain sensitivity¹³ Dysregulation of appetite and glucose metabolism¹⁴ In older adults, REM fragmentation has also been linked to accelerated cognitive decline  and increased risk of neurodegenerative disease¹⁵. These associations are particularly relevant for patients using THC nightly for insomnia, pain, or anxiety—conditions already sensitive to sleep quality. THC vs. CBD: An Important Distinction It is essential to differentiate THC  from cannabidiol (CBD) : Compound REM Effect Sedation Architecture Impact THC Suppresses REM Yes Disruptive CBD Neutral or mild REM normalization Variable Minimal CBD does not activate CB1 receptors directly and appears far less disruptive to sleep architecture¹⁶. Unfortunately, many commercially available products contain far more THC than advertised , especially edibles and vape formulations. Clinical Perspective: What Patients Should Know From a physician’s standpoint, THC is not a benign sleep aid . While it may reduce sleep latency, it does so at the cost of physiologic sleep integrity . Patients most at risk include: Nightly or near-nightly users Older adults Patients with mood disorders Individuals with cognitive concerns Patients with chronic pain or fibromyalgia For these individuals, THC may mask insomnia while worsening sleep quality over time . Practical Recommendations Avoid nightly THC use for sleep If used, limit dose and frequency Avoid THC within 4–6 hours of bedtime Consider sleep-supportive alternatives (behavioral therapy, circadian hygiene, targeted supplementation) For chronic users, taper gradually  to minimize REM rebound Objective sleep testing (actigraphy or polysomnography) may be appropriate in patients with persistent fatigue, cognitive complaints, or mood instability. Summary THC can make people feel sleepy—but it does not reliably produce healthy sleep . By suppressing REM sleep and altering normal architecture, THC interferes with the very processes that make sleep restorative. For patients seeking long-term cognitive health, emotional stability, and metabolic resilience, preserving REM sleep is not optional—it is essential . References Feinberg I, Jones R, Walker JM, Cavness C, March J.  Effects of marijuana extract and tetrahydrocannabinol on sleep patterns. Psychopharmacology (Berl).  1975;45(1):19–28. https://pubmed.ncbi.nlm.nih.gov/1102071/ Pivik RT, Zarcone VP Jr, Dement WC, Hollister LE.  Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Electroencephalogr Clin Neurophysiol.  1972;33(4):357–364. https://pubmed.ncbi.nlm.nih.gov/4116852/ Babson KA, Sottile J, Morabito D.  Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep.  2017;19(4):23. https://pubmed.ncbi.nlm.nih.gov/28349316/ Gates PJ, Albertella L, Copeland J.  The effects of cannabinoid administration on sleep: a systematic review. Sleep Med Rev.  2014;18(6):477–487. https://pubmed.ncbi.nlm.nih.gov/24794435/ Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Mechoulam R, Drucker-Colín R.  Cannabinoids and sleep. Sleep Med Rev.  2011;15(4):269–281. https://pubmed.ncbi.nlm.nih.gov/21185482/ Schierenbeck T, Riemann D, Berger M, Hornyak M.  Effect of illicit drugs on sleep: cannabis, cocaine, ecstasy, and heroin. Sleep Med Rev.  2008;12(5):381–389. https://pubmed.ncbi.nlm.nih.gov/18313952/ Budney AJ, Hughes JR, Moore BA, Vandrey R.  Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry.  2004;161(11):1967–1977. https://pubmed.ncbi.nlm.nih.gov/15514401/ Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL.  Dose-related neurocognitive effects of marijuana use. J Int Neuropsychol Soc.  2002;8(5):678–688. https://pubmed.ncbi.nlm.nih.gov/12164673/ Walker MP, Stickgold R.  Sleep-dependent learning and memory consolidation. Neuron.  2004;44(1):121–133. https://pubmed.ncbi.nlm.nih.gov/15450165/ Goldstein AN, Walker MP.  The role of sleep in emotional brain function. Nat Rev Neurosci.  2014;15(2):121–132. https://pubmed.ncbi.nlm.nih.gov/24473290/ Spiegel K, Leproult R, Van Cauter E.  Impact of sleep debt on metabolic and endocrine function. Lancet.  1999;354(9188):1435–1439. https://pubmed.ncbi.nlm.nih.gov/10543671/ Finan PH, Goodin BR, Smith MT.  The association of sleep and pain: an update. Pain.  2013;154(12):2347–2358. https://pubmed.ncbi.nlm.nih.gov/23790391/ Pase MP, Himali JJ, Grima NA, et al.  Sleep architecture and the risk of incident dementia in the community. Neurology.  2017;89(12):1244–1250. https://pubmed.ncbi.nlm.nih.gov/28842426/ Nicholson AN, Turner C, Stone BM, Robson P.  Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol.  2004;24(3):305–313. https://pubmed.ncbi.nlm.nih.gov/15186164/ Shannon S, Lewis N, Lee H, Hughes S.  Cannabidiol in anxiety and sleep: a large case series. Perm J.  2019;23:18–041. https://pubmed.ncbi.nlm.nih.gov/30624194/ Subscribe to our Blog   Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Discover how Huperzine A supports nitric oxide, brain function, circulation, and erectile health as part of a physician-guided, evidence-based wellness plan. Key Takeaways: Huperzine A boosts your nitric-oxide system, which supports your cognition, circulation, and tissue oxygenation simultaneously. preserves neurotransmitters that protect your memory, focus, and learning abilities. The supplement has also been proven to improve erectile dysfunction symptoms. A Huperzine A dosage above 400 µg daily can lead to negative side effects, such as nausea, sweating, or muscle twitching. Huperzine A has additional benefits, such as antioxidants, maintaining brain and heart tissue, and encouraging new neuron development. As a physician, I’m often asked whether any natural compounds  can enhance both mental and physical performance while also protecting long-term health. One intriguing candidate is Huperzine A —an extract from the Chinese club moss Huperzia serrata . Traditionally used in Eastern medicine for memory and clarity, this alkaloid has gained attention in modern research for its role in nitric oxide (NO)  signaling, neuroprotection , erectile dysfunction , and vascular function . If you want to improve your overall health with a natural supplement, we offer a Huperzine A supplement . What is Huperzine A? Huperzine A acts primarily as a reversible acetylcholinesterase inhibitor , meaning it helps preserve acetylcholine—the neurotransmitter critical for memory, focus, and learning. This mechanism is similar to that of several prescription drugs used for Alzheimer’s disease, but Huperzine A is naturally derived and, when properly dosed, generally well tolerated. Recent research also shows that it exerts secondary effects  that extend beyond the brain: it modulates nitric oxide synthase (NOS)  pathways, enhances endothelial function , and reduces oxidative stress —all vital for brain, cardiac, and sexual health. The Link Between Huperzine A and Nitric Oxide Nitric oxide is a gaseous signaling molecule produced by the endothelium (the lining of blood vessels) and certain neurons. It relaxes vascular smooth muscle, improves blood flow, supports neurotransmission, and acts as a key antioxidant mediator. Animal and cellular studies indicate that Huperzine A can: Up-regulate neuronal nitric oxide synthase (nNOS)  in the hippocampus, improving cerebral blood flow and synaptic signaling. Protect endothelial nitric oxide synthase (eNOS)  activity from oxidative damage, thereby sustaining vascular relaxation. Inhibit inducible NOS (iNOS)  expression under inflammatory stress, reducing harmful peroxynitrite formation. The result is a more balanced nitric-oxide system—supporting cognition, circulation, and tissue oxygenation simultaneously. Huperzine A increases Nitric Oxide at the Receptor Level Cognitive Benefits: Supporting Brain and Memory Function By preserving acetylcholine and enhancing NO-mediated blood flow, Huperzine A improves the brain’s “metabolic microcirculation.” Clinical trials in China involving patients with mild cognitive impairment and Alzheimer’s disease demonstrated measurable improvements in memory scores, attention, and daily function compared with placebo. Nitric oxide itself is a vasodilator within the brain, ensuring that neurons receive adequate glucose and oxygen. The dual action—neurochemical and vascular—makes Huperzine A an elegant, integrative approach for dementia prevention and early intervention . Erectile Function: Enhancing Vasodilation Naturally Erectile function depends on nitric oxide-driven vasodilation  of penile arteries. While phosphodiesterase-5 inhibitors (like sildenafil) increase cyclic-GMP response to NO, they don’t increase NO production itself. Huperzine A indirectly supports this system by preserving acetylcholine , which stimulates endothelial NO release, and by protecting eNOS  from oxidative stress. Animal studies suggest improved penile hemodynamics and reduced vascular inflammation when acetylcholinesterase inhibitors or cholinergic enhancers are used. For men with endothelial dysfunction, diabetes, or age-related decline , Huperzine A may serve as a supportive, non-pharmacologic adjunct to improve baseline nitric-oxide tone—potentially complementing standard therapies. When Nitric Oxide Goes Down, So Does Sexual Performance Cardiac and Vascular Health The same nitric-oxide pathways that affect cognition and erectile function also influence arterial flexibility, cardiac perfusion, and blood pressure regulation . Experimental studies show that Huperzine A: Protects cardiac mitochondria  from ischemia-reperfusion injury by reducing oxidative stress and maintaining nitric oxide balance. Improves endothelial function , enhancing blood flow and oxygen delivery to cardiac tissue. Reduces inflammatory cytokines  that otherwise impair eNOS activity. These effects suggest potential roles in supporting overall cardiovascular resilience—particularly for individuals with metabolic syndrome, hypertension, or early vascular disease. Additional Huperzine A Benefits Beyond its NO-modulating properties, Huperzine A demonstrates: Antioxidant activity , scavenging free radicals that can damage neurons and endothelium. Mitochondrial protection , helping maintain ATP production in brain and heart tissue. Neurogenesis support , through up-regulation of neurotrophic factors. Such broad protective effects make it a “systems-level” nutraceutical rather than a narrowly targeted one. Safety and Dosing Considerations Typical study doses range from 100–400 µg daily , divided twice per day. Because Huperzine A is a potent cholinesterase inhibitor, excess dosing can lead to cholinergic side effects —nausea, sweating, or muscle twitching. Patients already on prescription acetylcholinesterase inhibitors should avoid concurrent use without medical supervision. Individuals with bradycardia, peptic ulcer, or asthma should also consult a clinician before supplementation. Clinical Integration In practice, Huperzine A can be paired with: Citicoline  or alpha-GPC  to enhance cholinergic tone. L-citrulline  or beetroot extract  to further boost nitric oxide production. Antioxidants  like alpha-lipoic acid or resveratrol to protect endothelial NO. This synergistic combination targets the neurovascular unit —the intertwined system of neurons, glia, and blood vessels that governs both cognition and circulation. Summary Chart: Mechanistic and Clinical Effects Physiologic Target Mechanism of Huperzine A Effect on Nitric Oxide Clinical Implication Neurons (nNOS) Enhances synaptic signaling and blood flow ↑ NO generation Memory, focus, dementia prevention Endothelium (eNOS) Protects against oxidative inhibition Sustains NO-mediated vasodilation Cardiac perfusion, BP regulation Smooth muscle / vascular tissue Reduces inflammatory iNOS activity Balanced NO response Erectile and vascular function Mitochondria Lowers oxidative injury Indirect support Cardiac and neural energy metabolism The Bottom Line Huperzine A is more than a memory supplement.  By modulating nitric-oxide pathways and protecting both neurons and blood vessels, it bridges brain, heart, and sexual health—a rare triad of benefit in one natural compound. While not a replacement for prescription therapy, it can be a valuable adjunct in a comprehensive, physician-guided wellness plan emphasizing vascular integrity, metabolic control, and cognitive preservation. References Yang G, Wang Y, Sun J, et al. Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis. PLoS One . 2013. PLOS Xing S, Mak S, Zhang X, et al. Huperzine A in the treatment of Alzheimer’s disease and vascular dementia. CNS Neurosci Ther . 2014. PMC Rafii MS, Walsh S, Little JT, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology . 2011. PMC+1 Friedli MJ, Inestrosa NC. Huperzine A and its neuroprotective molecular signaling in Alzheimer’s disease. Molecules . 2021. MDPI Damar U, Gersner R, Johnstone JT, Schachter S, Rotenberg A. Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research. CNS Neurol Disord Drug Targets . 2016. PubMed Wong JC, Li J, Corbett BF, et al. Huperzine A provides robust and sustained protection against NMDA-induced excitotoxicity. Front Pharmacol . 2016. Frontiers Zheng CY, Tong JB, Li XH, et al. Huperzine A attenuates mitochondrial dysfunction after transient cerebral ischemia and reperfusion in mice. J Neurosci Res . 2008. Wiley Online Library Tao L, Ye CY, Yang L, et al. Acetylcholinesterase-independent protective effects of huperzine A against amyloid-β-induced mitochondrial dysfunction. Acta Pharmacol Sin . 2016. Nature Zhao HW, Zhang XJ, Xing C, Wang J. Ginkgolide A, ginkgolide B, and huperzine A inhibit nitric oxide formation and neurotoxicity in neuronal cultures. Int Immunopharmacol . 2002. ScienceDirect Wang ZF, Tang XC, Zhang HY. Huperzine A protects C6 glioma cells against oxygen–glucose deprivation by inhibiting inducible nitric oxide synthase and COX-2. FEBS Lett . 2007. ScienceDirect Sui X, Kong N, Ye L, et al. Huperzine A ameliorates damage induced by acute myocardial infarction in rats via antioxidative mechanisms. Int J Mol Med . 2014. Spandidos Publications+1 Zhang C, Xu Y, Zhang L, et al. Administration of huperzine A microspheres ameliorates myocardial ischemic injury via an α7nAChR-dependent JAK2/STAT3 signaling pathway. Drug Des Devel Ther . 2023. PubMed Yang Y, Li Z, Chen Y, et al. Protective effect of huperzine A against hepatic ischemia-reperfusion injury in mice. Eur J Pharmacol . 2014. PubMed Hu Q, Zhang H, Li S, et al. Huperzine A ameliorates neurological deficits after subarachnoid hemorrhage by inhibiting endothelial pyroptosis and oxidative stress. Brain Res . 2024. PMC+1 Li J, Zhang S, Wang J, et al. Huperzine A combined with hyperbaric oxygen improves cognitive function in elderly vascular dementia patients. Am J Transl Res . 2021. PMC+1 Dang TK, Pham NT, Bui TT, et al. Anti-neuroinflammatory effects of alkaloid-enriched extract of Huperzia squarrosa  in LPS-stimulated microglia. Pharm Biol . 2023. Taylor & Francis Online Burnett AL. The role of nitric oxide in erectile dysfunction: physiology and pharmacology. J Sex Med . 2007. PMC Birri MA, Budel JM, Dacome AS, et al. Huperzia saururus  facilitates male sexual response in spinal cord–transected rats. J Ethnopharmacol . 2014. ScienceDirect Yu P, Wang X, Liu X, et al. Huperzine A lowers intraocular pressure via M3 muscarinic receptor–mediated nitric oxide release. Ann Transl Med . 2021. Annals of Translational Medicine Cellular components of the blood–brain barrier and their role in nitric oxide–mediated endothelial dysfunction. J Vasc Med Surg . 2024. JSciMed Central Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Fatigue is one of the most common reasons patients walk through my door. Yet despite its prevalence, chronic fatigue is also among the most misunderstood  and misdiagnosed  complaints in modern medicine. Many people are told their labs are “normal,” or that exhaustion is simply a side effect of aging, stress, or not sleeping enough. But when fatigue becomes persistent—lasting weeks, months, or even years—it is almost always a symptom of an underlying metabolic, endocrine, or nutritional imbalance. This blog explains the often-overlooked medical causes of chronic fatigue , why standard labs frequently miss the diagnosis, and how a detailed integrative assessment can restore your energy, clarity, and quality of life. Why Fatigue Deserves a Deeper Look This infographic highlights eight medically significant causes of persistent fatigue—from thyroid and iron disorders to B12 deficiency, insulin resistance, mitochondrial problems, sleep apnea, and chronic infections Fatigue is not a diagnosis; it is a signal . The body is telling us that something fundamental is no longer functioning optimally—energy production, oxygen delivery, hormone balance, nutrient availability, or immunity. When fatigue persists despite rest, it warrants evaluation for core physiologic systems , including: Thyroid Iron metabolism Vitamin B12 and folate pathways Insulin resistance Adrenal function Mitochondrial energy production Chronic inflammation Sleep disorders Cardiac or pulmonary impairment Let’s break down each area and why it matters. 1. Thyroid Dysfunction: The Most Missed Endocrine Cause of Fatigue Many fatigued patients have been told their thyroid is “normal.” Unfortunately, this often means only TSH  was tested. TSH alone misses many cases of: Hypothyroidism Subclinical hypothyroidism Autoimmune thyroiditis (Hashimoto’s) Low T3 or impaired T4→T3 conversion A complete thyroid panel includes: TSH Free T4 Free T3 Reverse T3 TPO and thyroglobulin antibodies Even subtle abnormalities can cause profound fatigue, weight gain, cold intolerance, slowed cognition, and depression. 2. Iron Dysregulation: More Than Just “Anemia” Iron deficiency is a top cause of fatigue —but most clinicians check only hemoglobin and hematocrit. These become abnormal late , long after fatigue begins. The correct markers are: Ferritin  (ideal range for energy: ~70–150 ng/mL) Transferrin saturation Serum iron Total iron-binding capacity (TIBC) Iron deficiency without anemia (“IDWA”) is extremely common, especially in women, and can cause: Fatigue Hair loss Exercise intolerance Cognitive slowing Restless legs 3. Vitamin B12 and Folate Deficiency: The “Energy Vitamins” Low B12 and folate impair mitochondrial ATP production and red blood cell formation.Risk groups include: Older adults Vegetarians/vegans Patients on metformin Patients on acid-reducing medications Those with malabsorption Symptoms may mimic dementia: Fatigue Numbness/tingling Memory issues Balance problems MMA and homocysteine levels improve diagnostic accuracy far beyond serum B12 alone. 4. Insulin Resistance: The Silent Fatigue Driver Fatigue often reflects impaired glucose delivery to cells.Early insulin resistance can cause: Afternoon crashes Brain fog Sugar cravings Poor recovery from exercise Key labs: Fasting insulin HOMA-IR Hemoglobin A1c Fasting glucose Continuous glucose monitoring (optional) Improving insulin sensitivity frequently restores sustained energy throughout the day. 5. Adrenal Imbalance and Cortisol Dysregulation Chronic stress—emotional, metabolic, or inflammatory—can disrupt cortisol rhythms.Symptoms include: Morning exhaustion Anxiety Salt cravings Blood pressure swings “Tired but wired” at night A 4-point salivary or urinary cortisol mapping test reveals patterns not found in standard blood labs. 6. Mitochondrial Dysfunction: When Your Cells Can’t Make Energy The mitochondria produce ATP—your body’s energy currency. If their function declines, so does yours.Contributors include: Chronic inflammation Oxidative stress Toxin exposure Nutrient deficiencies Post-viral syndromes Supportive strategies often include: B vitamins Magnesium CoQ10 Alpha-lipoic acid L-carnitine NAD+ precursors 7. Sleep Disorders: The Overlooked Fatigue Multiplier Even mild sleep apnea, upper airway resistance syndrome (UARS), or fragmented sleep can cause profound daytime exhaustion.Symptoms include: Waking unrefreshed Morning headaches Snoring Nocturia Difficulty concentrating A home sleep study is often the quickest route to answers. 8. Chronic Inflammation and Hidden Infections Fatigue often accompanies persistent inflammatory states, including: Post-viral fatigue Autoimmune disease Long COVID Chronic sinusitis Occult urinary infections Dental infections Markers such as CRP, ESR, fibrinogen, and cytokine profiles can provide clarity. Cardiovascular and Pulmonary Contributors Even mild impairments in oxygen delivery cause fatigue: Microvascular dysfunction Early heart failure Arrhythmias Undiagnosed COPD or asthma Impaired diffusion capacity These are frequently missed until advanced. References Wouters HJ et al.  Association of anemia with fatigue. BMC Fam Pract. https://pubmed.ncbi.nlm.nih.gov/31623608/ Biondi B.  Hypothyroidism and fatigue. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(18)30020-0 Pearce SH, Brabant G.  Thyroid hormone and metabolism. N Engl J Med. https://doi.org/10.1056/NEJMra0801887 Camaschella C.  Iron-deficiency anemia. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/25901427/ Krayenbuehl P et al.  Intravenous iron for nonanemic fatigue. Blood. https://pubmed.ncbi.nlm.nih.gov/15860667/ O’Leary F, Samman S.  Vitamin B12 in the elderly. Drugs Aging. https://pubmed.ncbi.nlm.nih.gov/20608792/ Long AN, Atkinson MA.  Metformin-induced B12 deficiency. Diabetes Care. https://pubmed.ncbi.nlm.nih.gov/24963164/ Selhub J.  Folate, homocysteine and one-carbon metabolism. Annu Rev Nutr. https://pubmed.ncbi.nlm.nih.gov/12415148/ DeFronzo RA.  Insulin resistance: pathophysiologic basis. Diabetes. https://pubmed.ncbi.nlm.nih.gov/12502614/ Taylor R.  Pathogenesis of type 2 diabetes and fatigue relation. Diabetologia. https://pubmed.ncbi.nlm.nih.gov/28455707/ Young AH.  Cortisol dysregulation in mood disorders. Psychoneuroendocrinology. https://pubmed.ncbi.nlm.nih.gov/19733454/ Sapolsky RM.  Stress and the HPA axis. Endocr Rev. https://pubmed.ncbi.nlm.nih.gov/9759684/ Wallace DC.  Mitochondrial energetics and disease. Science. https://pubmed.ncbi.nlm.nih.gov/19965427/ Nicolson GL.  Mitochondrial dysfunction in chronic fatigue. J Clin Pathol. https://pubmed.ncbi.nlm.nih.gov/18796500/ Epstein LJ et al.  Sleep apnea consequences. Chest. https://pubmed.ncbi.nlm.nih.gov/19429713/ Kuna ST.  Mild sleep apnea effects. Sleep. https://pubmed.ncbi.nlm.nih.gov/18788643/ Proal AD, VanElzakker MB.  Chronic infections & fatigue. Front Immunol. https://pubmed.ncbi.nlm.nih.gov/31040890/ Rahman S, Thornton C.  Mitochondrial disease overview. BMJ. https://pubmed.ncbi.nlm.nih.gov/23077118/ Mensah GA.  Microvascular contributions to fatigue. Circulation. https://pubmed.ncbi.nlm.nih.gov/15117824/ Katz SD.  Cardiopulmonary impairment and exertional fatigue. JAMA. https://pubmed.ncbi.nlm.nih.gov/10866869/ Subscribe to our Blog   Sponsored by Stages of Life Vitamins 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Women are affected by UTI more often than are men. Symptoms vary from patient to patient, different with each infectious orgasm, and from time to time. Urinary tract infections (UTIs) are among the most common bacterial infections seen in outpatient medicine. For most patients, a standard urinalysis  followed by a culture and sensitivity  provides sufficient information for diagnosis and treatment. But for others—those with recurrent infections, persistent symptoms, multi-drug–resistant organisms, or atypical presentations—a more sensitive diagnostic tool may be needed. This is where urine PCR (polymerase chain reaction)  testing becomes invaluable. When used appropriately, PCR can identify pathogens that traditional cultures miss, providing critical information that guides proper antimicrobial therapy. However, it is essential to understand what PCR is—and what it is NOT designed to do.  PCR is not intended to confirm that an infection has cleared  after treatment. Instead, it is used to identify pathogens in patients who remain symptomatic  despite therapy or when initial testing yields inconclusive results. Why Urine PCR Matters in UTI Diagnosis This diagram demonstrates the first step in UTI diagnosis—urinalysis—before advancing to culture and PCR when symptoms persist. The PCR is incorporated into the diagnostic evaluation as illustrated, below: Urinalysis to PCR: Understanding the Reflex Testing Pathway for Persistent UTIs How Urine PCR Fits Into the UTI Diagnostic Workflow: Reflex Testing Explained Urine PCR is a molecular test that detects microbial DNA. Unlike culture, which requires organisms to grow on a medium, PCR amplifies genetic material directly, allowing for: 1. Higher Sensitivity Some pathogens grow poorly or not at all on standard culture media. PCR can detect organisms present in low colony counts or those fully missed by culture. 2. Faster Turnaround Time PCR results often return within 24 hours, while cultures may take 48–72 hours. 3. Detection of Fastidious and Atypical Organisms Examples include: Ureaplasma Mycoplasma Chlamydia trachomatis Gardnerella Slow-growing gram-negative rods. These species may be clinically significant in recurrent or persistent infections but are frequently culture-negative. 4. Identification of Resistance Genes PCR panels can detect genes associated with: ESBL (extended-spectrum beta-lactamases) Carbapenem resistance Fluoroquinolone resistanceThis information helps tailor antimicrobial therapy without waiting days for culture plates. What Urine PCR Should NOT Be Used For: Despite its sensitivity, urine PCR should not  be used to determine whether a patient’s infection is gone . The test is so sensitive that it may detect residual, non-viable bacterial DNA long after the infection has clinically resolved. ✔ Do NOT use PCR as a “test of cure.” Instead: ✔ Use PCR only if symptoms persist after treatment , or ✔ If initial culture results did not match the clinical picture. This separation of purpose prevents overtreatment and avoids unnecessary antibiotics based solely on residual DNA fragments. When to Repeat a Urine PCR PCR may be repeated only when symptoms persist , or when the infection worsens despite standard therapy. In this context, repeat PCR can: Identify resistant organisms that emerged after treatment Reveal mixed infections not seen on initial culture Detect non-traditional pathogens Guide combination therapy in complex cases This strategy prevents chronic cycles of undertreated or misdiagnosed UTIs. How PCR Fits Into the Standard Diagnostic Workflow Most UTIs follow a standard pathway: Urinalysis (UA) Looks for nitrites, leukocyte esterase, pyuria, bacteriuria First-line screening test Urine Culture and Sensitivity Identifies bacteria that grow on culture media Determines antibiotic susceptibility PCR (Reflex Testing) PCR is used when: Culture is negative but symptoms persist Organisms are suspected but not growing Recurrent UTIs suggest hidden pathogens Fastidious organisms are likely Resistance patterns require clarification Clinical Scenarios Where Urine PCR Is Especially Helpful “Urine PCR is most beneficial in recurrent infections, persistent symptoms, prostatitis-like presentations, and culture-negative UTIs. Recurrent UTIs PCR may show mixed infections or atypical organisms. Post-treatment persistent symptoms PCR identifies what culture may miss. High Sensitivity. Interstitial cystitis vs chronic infectious cystitis PCR helps differentiate inflammatory vs infectious etiologies. Men with prostatitis-like symptoms PCR often reveals hidden pathogens not detected via culture . Elderly patients with atypical presentations High sensitivity avoids missed infections. Immunocompromised patients More accurate detection of low-burden infections. Clinical Limitations of Urine PCR Even though PCR is highly sensitive, it has limitations: Cannot quantify bacterial load meaningfully Detects DNA of non-viable organisms May detect colonization rather than infection Does not replace a standard culture in antibiotic stewardship Therefore, PCR is a supplemental tool , not a stand alone diagnostic. Conclusion Urine PCR is a powerful diagnostic tool when used appropriately. For patients with persistent symptoms , refractory UTIs , or culture-negative but clinically convincing infections , PCR provides clarity that traditional testing cannot. It detects fastidious organisms, identifies resistance genes, and guides targeted therapy—helping prevent chronic or recurrent infections. But PCR should not  be used as a “test of cure.” It is reserved for situations where additional diagnostic information is needed to guide ongoing care. At Stages of Life Medical Institute, we use urine PCR judiciously—ensuring patients receive the most accurate diagnosis and the most appropriate, evidence-based treatment. References Price TK, et al. The clinical urine culture: a paradigm shift for urinary microbiome research.  Clin Microbiol Rev. 2018. https://pubmed.ncbi.nlm.nih.gov/29743372/ Hilt EE, et al. Urine is not sterile: use of enhanced urine culture techniques.  J Clin Microbiol. 2014. https://pubmed.ncbi.nlm.nih.gov/24685850/ Wolfe AJ, Brubaker L. “Sterile” urine—still a scientific myth?  Nat Rev Urol. 2015. https://pubmed.ncbi.nlm.nih.gov/25535261/ Pearce MM, et al. The female urinary microbiome: a new clinical paradigm.  Nat Rev Urol. 2014. https://pubmed.ncbi.nlm.nih.gov/25133040/ Scheepe JR, et al. Utility of PCR testing for urinary tract infections: a review.  Int Urogynecol J. 2020. https://pubmed.ncbi.nlm.nih.gov/31965210/ Almassi N, et al. Impact of molecular testing on management of UTIs.  Curr Urol Rep. 2021. https://pubmed.ncbi.nlm.nih.gov/33409703/ Marrazzo JM, et al. Fastidious organisms in urinary diagnostics.  Clin Infect Dis. 2014. https://pubmed.ncbi.nlm.nih.gov/24352347/ Kline KA, Lewis AL. Gram-positive uropathogens and diagnostic challenges.  Curr Opin Microbiol. 2016. https://pubmed.ncbi.nlm.nih.gov/26828508/ Farkash EA, et al. Rapid PCR detection of bacteria in urine.  J Clin Microbiol. 2012. https://pubmed.ncbi.nlm.nih.gov/22205813/ O’Donnell JA, et al. PCR for detection of ESBL genes in urinary pathogens.  Antimicrob Agents Chemother. https://pubmed.ncbi.nlm.nih.gov/21576552/ Lee BS, Bhuta T. Limitations of culture in urinary diagnostics.  Curr Opin Pediatr. https://pubmed.ncbi.nlm.nih.gov/21716186/ Harding SA, et al. PCR in diagnosis of persistent urinary infections.  Infect Dis Clin. https://pubmed.ncbi.nlm.nih.gov/29103780/ Bekeris LG, et al. Molecular detection vs culture methods.  Arch Pathol Lab Med. https://pubmed.ncbi.nlm.nih.gov/18788825/ Epp A, et al. Recurrent urinary tract infection diagnosis and management.  J Obstet Gynaecol Can. https://pubmed.ncbi.nlm.nih.gov/28061109/ Foxman B. Epidemiology of UTIs and diagnostic accuracy.  Infect Dis Clin North Am. https://pubmed.ncbi.nlm.nih.gov/18524587/ Gupta K, et al. IDSA guidelines for UTI diagnosis.  Clin Infect Dis. https://pubmed.ncbi.nlm.nih.gov/21292654/ O’Brien VP, et al. Host-pathogen interactions in persistent UTIs.  Nat Rev Microbiol. https://pubmed.ncbi.nlm.nih.gov/31413268/ Lewis DA. Challenges in diagnosis of complicated UTIs.  Curr Opin Infect Dis. https://pubmed.ncbi.nlm.nih.gov/30531310/ Brubaker L, et al. Recurrent UTI and microbiome.  J Urol. https://pubmed.ncbi.nlm.nih.gov/27692718/ Zimmern P, et al. Role of molecular diagnostics in UTI evaluation.  Curr Bladder Dysfunct Rep. https://pubmed.ncbi.nlm.nih.gov/32300842/ Subscribe to our Blog   Sponsored by Stages of Life Vitamins 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com